April 12, 2018 / 9:44 PM / 7 months ago

BRIEF-Ampio Updates Regulatory, Clinical And NYSE Activities

April 12 (Reuters) - Ampio Pharmaceuticals Inc:

* AMPIO UPDATES REGULATORY, CLINICAL AND NYSE ACTIVITIES

* BEGUN PRELIMINARY DISCUSSIONS WITH FDA ON DETAILS OF BLA SUBMISSION PROCESS FOR AMPION

* RECEIVED NOTIFICATION LETTER FROM NYSE CONFIRMING CO IS NOW IN FULL COMPLIANCE WITH LISTING REQUIREMENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below